Peripheral T Cell Subpopulations as a Potential Surrogate Biomarker during Atezolizumab plus Bevacizumab Treatment for Hepatocellular Carcinoma.
Shirane Y, Fujii Y, Ono A, Nakahara H, Hayes CN, Miura R, Murakami S, Sakamoto N, Uchikawa S, Fujino H, Nakahara T, Murakami E, Yamauchi M, Miki D, Kawaoka T, Arihiro K, Tsuge M, Oka S.
Shirane Y, et al. Among authors: oka s.
Cancers (Basel). 2024 Mar 28;16(7):1328. doi: 10.3390/cancers16071328.
Cancers (Basel). 2024.
PMID: 38611007
Free PMC article.